Status:
NOT_YET_RECRUITING
Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters
Lead Sponsor:
Atlantic Health System
Conditions:
Vaginal Infection
Vaginal Discharge
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
LiviWell has developed a product designed for postcoital semen absorption. Previous studies have demonstrated the product rapidly absorbs semen, and leads to less symptoms of postcoital vaginal microb...
Detailed Description
LiviWell's consumer hygiene device is a post-coital vaginal insert called "Livi". Livi is comprised of an applicator, with a medical-grade polyurethane foam and retrieval string. It is designed to be ...
Eligibility Criteria
Inclusion
- Over 18 (for pH subset, 18-45)
- Sexually-active with biological men
- Willing and able to use product
- Resides in continental USA
- Understands, reads, writes, and speaks English
Exclusion
- Currently Pregnant or are trying to conceive
- Unable to use device due to poor motor function
- Unable to sign informed consent
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06530186
Start Date
August 1 2024
End Date
January 31 2025
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Garden State Urology
Mountain Lakes, New Jersey, United States, 07046